This article is rated B-class on Wikipedia's
content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||
|
Ideal sources for Wikipedia's health content are defined in the guideline
Wikipedia:Identifying reliable sources (medicine) and are typically
review articles. Here are links to possibly useful sources of information about Goodpasture syndrome.
|
This article was the subject of a Wiki Education Foundation-supported course assignment, between 8 January 2020 and 25 March 2020. Further details are available on the course page. Student editor(s): Reeny2020.
Above undated message substituted from Template:Dashboard.wikiedu.org assignment by PrimeBOT ( talk) 22:32, 16 January 2022 (UTC)
Is there any citation for this statement, which seems counterintuitive: "and these infections may result in a worsening of the primary disease". It's not clear that infections will actually exacerbate circulating anti-GBM antibodies or autoimmune response to the GBM. I have removed that clause pending some kind of citation for this. Derek Balsam 00:18, 14 May 2007 (UTC)
It is type 2 noncytotoxic, correct? Tkjazzer 20:56, 11 November 2007 (UTC)
PMID 11388816 - 2001 early treatment seems to be good. JFW | T@lk 19:23, 16 June 2008 (UTC)
Anti-GBM disease is not equal to Goodpasture's syndrome. Here is a quote from Harrison's: "Patients who develop autoantibodies directed against glomerular basement antigens frequently develop a glomerulonephritis termed antiglomerular basement membrane (anti-GBM) disease. When they present with lung hemorrhage and glomerulonephritis, they have a pulmonary-renal syndrome called Goodpasture's syndrome." Anti-GBM disease can be part of Goodpasture's syndrome but can also present on its own. This distinction should be made more clear, especially as many patients with Anti-GBM disease might get wrongfully worried about their lungs (thinking they have Goodpasture's). -- Bastilleday uky ( talk) 03:04, 30 September 2009 (UTC)